|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM380273454 |
003 |
DE-627 |
005 |
20241126232350.0 |
007 |
cr uuu---uuuuu |
008 |
241116s2024 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1021/acs.langmuir.4c03206
|2 doi
|
028 |
5 |
2 |
|a pubmed24n1613.xml
|
035 |
|
|
|a (DE-627)NLM380273454
|
035 |
|
|
|a (NLM)39540901
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Zhang, Xu
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Antimicrobial GL13K Peptide-Decorated ZnO Nanoparticles To Treat Bacterial Infections
|
264 |
|
1 |
|c 2024
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 26.11.2024
|
500 |
|
|
|a Date Revised 26.11.2024
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a As a broad-spectrum antimicrobial material, ZnO nanoparticles (NPs) offer a novel approach to infected wounds in the clinic; however, it is very necessary to improve the antimicrobial performance of ZnO to satisfy the clinic requirements. In this work, a new antimicrobial hybrid ZnOPDA/GL13K was prepared by attaching the antimicrobial GL13K peptide on the surface of ZnO NPs via polydopamine (PDA) as a covalent bonding agent, which can enhance the reactive oxygen species (ROS) production and damage the cell wall, showing superior antimicrobial efficacy. Besides, the ZnO@PDA/GL13K hybrid can promote the healing of bacterial infected wounds, with the wound area only remaining 1.8% on day 9, about 2 times smaller than that of the ZnO group. Moreover, ZnO@PDA/GL13K also showed good biocompatibility, and no side effect on normal tissue and organs was found, implying that the antimicrobial hybrid may possess prospective application in biomedical fields
|
650 |
|
4 |
|a Journal Article
|
650 |
|
7 |
|a Zinc Oxide
|2 NLM
|
650 |
|
7 |
|a SOI2LOH54Z
|2 NLM
|
650 |
|
7 |
|a Anti-Bacterial Agents
|2 NLM
|
650 |
|
7 |
|a Indoles
|2 NLM
|
650 |
|
7 |
|a polydopamine
|2 NLM
|
650 |
|
7 |
|a Polymers
|2 NLM
|
650 |
|
7 |
|a Reactive Oxygen Species
|2 NLM
|
650 |
|
7 |
|a Antimicrobial Peptides
|2 NLM
|
700 |
1 |
|
|a Liu, Yinghao
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zhang, Xue'e
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Tang, Mengzhen
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Xi, Weihong
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wei, Junchao
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Langmuir : the ACS journal of surfaces and colloids
|d 1999
|g 40(2024), 47 vom: 26. Nov., Seite 25042-25050
|w (DE-627)NLM098181009
|x 1520-5827
|7 nnns
|
773 |
1 |
8 |
|g volume:40
|g year:2024
|g number:47
|g day:26
|g month:11
|g pages:25042-25050
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1021/acs.langmuir.4c03206
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_22
|
912 |
|
|
|a GBV_ILN_350
|
912 |
|
|
|a GBV_ILN_721
|
951 |
|
|
|a AR
|
952 |
|
|
|d 40
|j 2024
|e 47
|b 26
|c 11
|h 25042-25050
|